Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Donna D'Souza
Therapeutic Response of Metastatic Colorectal Cancer Harboring aKRASMissense Mutation After Combination Chemotherapy With the EGFR Inhibitor Panitumumab
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Related publications
Patients Harboring EGFR Mutation After Primary Resistance to Crizotinib and Response to EGFR-tyrosine Kinase Inhibitor
OncoTargets and Therapy
Oncology
Pharmacology
Metastatic Colorectal Carcinoma: Response to Panitumumab
Journal of the Bahrain Medical Society
Panitumumab: The Evidence of Its Therapeutic Potential in Metastatic Colorectal Cancer Care
Core Evidence
Medicine
Reviews
References
Pharmacology
Combination of EGFR-TKIs With Chemotherapy Versus Chemotherapy or EGFR-TKIs Alone in Advanced NSCLC Patients With EGFR Mutation
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination With Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
BioDrugs
Medicine
Biotechnology
Pharmacology
Afatinib in Locally Advanced/Metastatic NSCLC Harboring Common EGFR Mutations, After Chemotherapy: A Phase IV Study
Lung Cancer Management
Health-Related Quality of Life and Colorectal Cancer-Specific Symptoms in Patients With Chemotherapy-Refractory Metastatic Disease Treated With Panitumumab
International Journal of Colorectal Disease
Gastroenterology
Clinical Outcome of Treatment of Metastatic Non-Small Cell Lung Cancer in Patients Harboring Uncommon EGFR Mutation
BMC Cancer
Cancer Research
Oncology
Genetics
Combination Chemotherapy in Metastatic Breast Cancer
BMJ
